Published in Infect Immun on June 01, 1997
Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev (1998) 7.89
Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol (2011) 1.93
Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun (1998) 1.44
Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect Immun (2000) 1.31
Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc Natl Acad Sci U S A (1999) 1.29
STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection. J Immunol (2004) 1.06
In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application. Infect Immun (2002) 1.01
Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma. PLoS One (2010) 0.99
Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis. Infect Immun (2001) 0.97
NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp. Infect Immun (2005) 0.96
A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur J Immunol (2009) 0.96
Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice. Infect Immun (2001) 0.95
Identification of early interactions between Francisella and the host. Infect Immun (2014) 0.91
Surfactant dysfunction in SP-A-/- and iNOS-/- mice with mycoplasma infection. Am J Respir Cell Mol Biol (2006) 0.90
Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae. PLoS One (2010) 0.90
EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis. FEMS Microbiol Lett (2012) 0.84
The Vsa shield of Mycoplasma pulmonis is antiphagocytic. Infect Immun (2011) 0.82
Depletion of alveolar macrophages in CD11c diphtheria toxin receptor mice produces an inflammatory response. Immun Inflamm Dis (2015) 0.79
Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis. Am J Respir Cell Mol Biol (2013) 0.79
Differential interleukin-10 and gamma interferon mRNA expression in lungs of cilium-associated respiratory bacillus-infected mice. Infect Immun (2001) 0.78
Antibody and cytokine responses to the cilium-associated respiratory bacillus in BALB/c and C57BL/6 mice. Infect Immun (2000) 0.77
NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization. J Immunol (2009) 0.77
Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor. Comp Med (2014) 0.75
Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses. PLoS One (2016) 0.75
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods (1994) 13.53
Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med (1989) 3.01
The liposome-mediated macrophage 'suicide' technique. J Immunol Methods (1989) 2.73
Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis (1993) 2.45
Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol (1994) 2.34
Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res (1990) 1.97
Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res (1984) 1.91
Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J Leukoc Biol (1989) 1.71
Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs. immunity. Eur J Immunol (1991) 1.59
Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect Immun (1988) 1.54
Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect Immun (1995) 1.50
Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice. Infect Immun (1985) 1.49
Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis (1992) 1.48
Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science (1983) 1.38
Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect Immun (1995) 1.36
Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro. Infect Immun (1980) 1.35
Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J Biol Med (1984) 1.34
Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J Appl Physiol (1985) (1993) 1.29
Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice. Infect Immun (1987) 1.26
Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J Exp Med (1993) 1.10
Resistance to Mycoplasma pulmonis mediated by activated natural killer cells. J Infect Dis (1990) 1.09
Decreased intrapulmonary killing of Mycoplasma pulmonis after short-term exposure to NO2 is associated with damaged alveolar macrophages. Am Rev Respir Dis (1992) 1.06
Preparation and characteristics of dichloromethylene diphosphonate-containing liposomes. J Microencapsul (1989) 1.03
Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis. Am Rev Respir Dis (1989) 0.98
Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis. Clin Exp Immunol (1994) 0.96
Mycoplasma pulmonis infection augments natural killer cell activity in mice. Lab Anim Sci (1987) 0.91
Liposome mediated depletion of macrophages: an approach for fundamental studies. J Drug Target (1994) 0.89
Histochemical demonstration of enzyme activities in plastic and paraffin embedded tissue sections. Stain Technol (1979) 0.87
Protein content of lung lavage fluid of guinea pigs exposed to 0.4 ppm nitrogen dioxide. Arch Environ Health (1973) 0.85
Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomes. Biochim Biophys Acta (1986) 0.85
Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Recent Results Cancer Res (1989) 0.81
Cytotoxicity of dichloromethane diphosphonate and of 1-hydroxyethane-1,1-diphosphonate in the amoebae of the slime mould Dictyostelium discoideum. A 31P NMR study. Biochem Pharmacol (1992) 0.81
The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron. Calcif Tissue Int (1993) 0.80
Nitrogen dioxide exposure and lung antioxidants in ascorbic acid-deficient guinea pigs. Toxicol Appl Pharmacol (1986) 0.80
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science (1976) 2.78
Effective immunity to dental caries: protection of gnotobiotic rats by local immunization with Streptococcus mutans. J Immunol (1975) 2.71
Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol (1971) 2.66
Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest (1978) 2.64
Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol (2000) 2.54
IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A (1987) 2.37
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc Natl Acad Sci U S A (1998) 2.22
The role of environmental ammonia in respiratory mycoplasmosis of rats. Am J Pathol (1976) 2.15
Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol (1973) 2.14
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J Infect Dis (1980) 2.11
An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages. J Immunol Methods (1982) 2.06
Immunobiology of dental caries: microbial aspects and local immunity. Annu Rev Microbiol (1981) 2.04
Mycoplasma pulmonis and lymphoma in bioassays in rats. Vet Pathol (2009) 2.03
Cariogenicity of Streptococcus mutans V403 glucosyltransferase and fructosyltransferase mutants constructed by allelic exchange. Infect Immun (1991) 2.00
Virulence of Streptococcus mutans: a sensitive method for evaluating cariogenicity in young gnotobiotic rats. Infect Immun (1975) 2.00
Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum Mol Genet (2001) 1.93
Virulence of Streptococcus mutans: biochemical and pathogenic characteristics of mutant isolates. Proc Soc Exp Biol Med (1975) 1.73
Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens. J Exp Med (1979) 1.73
Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol (1998) 1.69
Rat immunoglobulins in serum and secretions: purification of rat IgM, IgA and IgG and their quantitation in serum, colostrum, milk and saliva. Immunochemistry (1975) 1.61
Autosomal dominant erythromelalgia. Am J Med Genet (1992) 1.61
Genetic characterization of a Streptococcus mutans LraI family operon and role in virulence. Infect Immun (2000) 1.55
Immune response of pathogen-free mice inoculated intranasally with Mycoplasma pulmonis. J Immunol (1974) 1.54
Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats. Mol Microbiol (2001) 1.54
Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect Immun (1988) 1.54
Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect Immun (1995) 1.50
Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol (2001) 1.49
Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. J Immunol (1984) 1.48
Concept of the local and common mucosal immune response. Adv Exp Med Biol (1978) 1.46
Virulence of Streptococcus mutans: comparison of the effects of a coupling sugar and sucrose on certain metabolic activities and cariogenicity. Infect Immun (1978) 1.46
Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun (1998) 1.44
Effective immunity to dental caries: dose-dependent studies of secretory immunity by oral administration of Streptococcus mutans to rats. Infect Immun (1978) 1.41
Equine goiter due to excess dietary iodide. J Am Vet Med Assoc (1968) 1.41
Detection of natural Mycoplasma pulmonis infection in rats and mice by an enzyme linked immunosorbent assay (ELISA). Lab Anim Sci (1981) 1.41
Virulence of a spaP mutant of Streptococcus mutans in a gnotobiotic rat model. Infect Immun (1999) 1.40
In vivo immune response to a T-cell-dependent antigen by cultures of disassociated murine Peyer's patch. Proc Natl Acad Sci U S A (1982) 1.39
Pathogen status in the 1990s: abused terminology and compromised principles. Lab Anim Sci (1998) 1.38
Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect Immun (1995) 1.36
Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency. Science (1971) 1.35
Biochemical characterization and evaluation of virulence of a fructosyltransferase-deficient mutant of Streptococcus mutans V403. Infect Immun (1989) 1.35
Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect Immun (2000) 1.34
Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man. J Neuropathol Exp Neurol (1973) 1.32
Analysis of the virulence of Streptococcus mutans serotype c gtfA mutants in the rat model system. Infect Immun (1988) 1.32
Isotype specificity of helper T cell clones. Peyer's patch Th cells preferentially collaborate with mature IgA B cells for IgA responses. J Exp Med (1984) 1.31
Murine Peyer's patch T cell clones. Characterization of antigen-specific helper T cells for immunoglobulin A responses. J Exp Med (1982) 1.30
Virulence of Streptococcus mutans: cariogenicity of S. mutans in adult gnotobiotic rats. Infect Immun (1977) 1.30
Inactivation of the gbpA gene of Streptococcus mutans increases virulence and promotes in vivo accumulation of recombinations between the glucosyltransferase B and C genes. Infect Immun (1998) 1.30
Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc Natl Acad Sci U S A (1999) 1.29
Effect of host responses on the pathogenicity of strains of Porphyromonas gingivalis. Oral Microbiol Immunol (1996) 1.28
Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model. Infect Immun (1999) 1.28
Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect Immun (1997) 1.27
Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J Immunol (1982) 1.26
Respiratory and genital mycoplasmosis of laboratory rodents: implications for biomedical research. Isr J Med Sci (1981) 1.25
Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect Immun (1993) 1.25
Comparative analysis of the antibacterial effects of combined mouthrinses on Streptococcus mutans. Oral Microbiol Immunol (2005) 1.25
A plastic intraoral device for the collection of human parotid saliva. J Dent Res (1977) 1.21
Cellular basis for elevated IgA responses in C3H/HeJ mice. J Immunol (1980) 1.20
Intracage ammonia promotes growth of Mycoplasma pulmonis in the respiratory tract of rats. Infect Immun (1982) 1.20
Effective immunity to dental caries: enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants. Infect Immun (1983) 1.20
Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb. Infect Immun (2000) 1.19
Lack of oral tolerance in C3H/HeJ mice. J Exp Med (1982) 1.19
Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol (1982) 1.19
Isotype-specific immunoregulation. IgA-binding factors produced by Fc alpha receptor-positive T cell hybridomas regulate IgA responses. J Exp Med (1985) 1.17
Role of M protein in pharyngeal colonization by group A streptococci in rats. Infect Immun (1993) 1.16
Natural mycoplasmal infections in isolator-maintained LEW/Tru rats. Lab Anim Sci (1988) 1.16
Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance. Hum Gene Ther (1998) 1.14
Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol (1999) 1.14
Lack of amiloride-sensitive transport across alveolar and respiratory epithelium of iNOS(-/-) mice in vivo. Am J Physiol Lung Cell Mol Physiol (2001) 1.13
Effective immunity to dental caries: protection of gnotobiotic rats by local immunization with a ribosomal preparation from Streptococcus mutans. Microbiol Immunol (1983) 1.12
Intrauterine choriocarcinoma in a rhesus monkey. Pathol Vet (1969) 1.12
Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am J Physiol (1998) 1.12
Low sucrose levels promote extensive Streptococcus mutans-induced dental caries. Infect Immun (1977) 1.11
Systemic immunity after local antigenic stimulation of the lymphoid tissue of the gastrointestinal tract. J Immunol (1973) 1.11
Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res (1997) 1.10
Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy. Am J Pathol (1998) 1.09
Lipopolysaccharide (LPS) regulation of the immune response: T lymphocytes from normal mice suppress mitogenic and immunogenic responses to LPS. J Immunol (1980) 1.09
Effects of Porphyromonas gingivalis and Escherichia coli lipopolysaccharides on mononuclear phagocytes. Infect Immun (1997) 1.08
Health care for research animals is essential and affordable. FASEB J (1997) 1.07
Virulence of Streptococcus mutans: an antibiotic-suppressed rat model for studies of pathogenesis. J Dent Res (1977) 1.07
Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res (1997) 1.07
Use of mutants in the elucidation of virulence of Streptococcus mutans. Adv Exp Med Biol (1978) 1.06
Decreased intrapulmonary killing of Mycoplasma pulmonis after short-term exposure to NO2 is associated with damaged alveolar macrophages. Am Rev Respir Dis (1992) 1.06
Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin. Infect Immun (1996) 1.06
Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect Immun (1993) 1.06
LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice. J Immunol (1984) 1.05
Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. J Clin Invest (1991) 1.05
Comparison of methods for detection of Mycoplasma pulmonis in experimentally and naturally infected rats. J Clin Microbiol (1981) 1.05
Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect Immun (1998) 1.04
Protective immunity against Streptococcus mutans infection in mice after intranasal immunization with the glucan-binding region of S. mutans glucosyltransferase. Infect Immun (1999) 1.03
Cloning of a locus involved in Streptococcus mutans intracellular polysaccharide accumulation and virulence testing of an intracellular polysaccharide-deficient mutant. Infect Immun (1992) 1.03
Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. Hum Mol Genet (2000) 1.02
Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells. Infect Immun (2001) 1.02
Effective immunity to dental caries: gastric intubation of Streptococcus mutans whole cells or cell walls induces protective immunity in gnotobiotic rats. Infect Immun (1983) 1.01
Exacerbation of murine respiratory mycoplasmosis in gnotobiotic F344/N rats by Sendai virus infection. Vet Pathol (1985) 1.01
Dexamethasone and oxytetracycline reverse the potentiation of neurogenic inflammation in airways of rats with Mycoplasma pulmonis infection. Am J Respir Crit Care Med (1994) 1.00